CMMB - Chemomab Therapeutics - ADR GAAP EPS of -$0.04 in-line
2023-05-11 11:44:29 ET
- Chemomab Therapeutics - ADR press release ( NASDAQ: CMMB ): Q1 GAAP EPS of -$0.04 in-line.
- Cash Position: Cash, cash equivalents and short-term bank deposits were $32.8 million as of March 31, 2023, compared to $39.9 million at December 31, 2022.
For further details see:
Chemomab Therapeutics - ADR GAAP EPS of -$0.04 in-line